NEWS UPDATES
by www.healthcareafrica.info DIGITAL HEALTH
Abu Dhabi Sovereign Fund buys 3% stake in Intas Pharma
Morocco starts construction of US$599 million Ibn Sina Hospital to bolster healthcare MOROCCO – Moroccan King Mohammed VI has officially initiated the construction of US$559 million Ibn Sina Hospital with a capacity of more than 1,000 beds to strengthen healthcare delivery in the Rabat-SaleKenitra region. The construction of the Moroccan Ibn Sina Hospital involves a hospitalization tower, a medicaltechnical center with five floors, 11-floor tower dedicated to the National League for the Fight
THE FACILITY WILL OFFER QUALITY HEALTH SERVICES INCLUDING INTENSIVE CARE, OUTPATIENT CARE, EMERGENCIES, SEVERE BURNS AND FOLLOW-UP CARE, & REHABILITATIVE SERVICES
against Cardiovascular Diseases, a Conference Center, Training Center and a Boarding School. The facility will offer quality health services including intensive care, outpatient care, emergencies, severe burns and follow-up care, rehabilitative services, respiratory illness treatment, dialysis care among other medical services. The hospital tower project covering an area totaling 11.4 hectares meets the standards of bio-climatic and sustainable development and it is estimated to be complete in 4 years. It will be 140 meters high with 34 floors and 3 floors below ground level.
HEALTHCARE DELIVERY
Apollo Hospitals introduces new foot reconstruction treatment for diabetic patients INDIA – Apollo Hospitals has opened a unique multidisciplinary Centre of Excellence for Diabetic Foot Management (CoEDFM) for diabetic patients who are known to be prone to foot-related ailments at its Jubilee Hills location. Apollo Hospitals will offer a novel Diabetic Foot Reconstruction & Management procedure for the first time in India to patients at the new multidisciplinary health facility in collaboration with King’s College Hospital in London. CoEDFM will use a multidisciplinary treatment protocol for diabetic foot ailments, which can be traumatic and HEALTHCAREAFRICA.INFO
life-threatening. The new technique employs the international fixation method, which includes the use of special devices such as beams, bolts, and specially designed plates and nails.
UAE – The Abu Dhabi Investment Authority (ADIA), a sovereign wealth fund owned by Abu Dhabi Emirate has acquired approximately 3% of Intas Pharmaceuticals for US$250US$270 million (2,000 crore) at a valuation of US$8.5 billion (65,000 crore). ADIA is set to purchase 3% stake from current investor Temasek Holdings, which currently owns about 10% of the Indian drug company. ADIA, which has property worth approximately US$800 billion, has received a lot of attention in India, and has invested more than US$3 billion in India since 2018. It has invested in major Indian companies like Flipkart, Reliance Retail, Mindspace REIT, HDFC Capital, Mphasis, Paytm, Nykaa and Mobikwik. The Chudgar family, Intas’ promoters, currently owns 84% of Intas, while homegrown PE fund ChrysCapital owns 6%.
Pfizer to buy Biohaven in US$11.6 billion deal, marks comeback in neuro arena USA – Pfizer Inc has announced that it will pay US$11.6 billion for Biohaven Pharmaceutical Holding Co, a large bet on the company’s ability to increase sales of the top-selling pill in a new class of migraine drugs. The acquisition follows a Nurtec commercialization agreement signed by the companies in November 2021. The current transaction follows Pfizer’s US$6.7 billion acquisition of Arena Pharmaceuticals to gain access to the latter’s S1P modulator for inflammatory diseases. In a smaller deal, Pfizer will pay US$525 million for respiratory syncytial virus specialist ReViral.
MAY/JUNE 2022 | HEALTHCARE AFRICA
5
